Recent publications
Genetic interaction mapping and exon-resolution functional genomics with a hybrid Cas9–Cas12a platform. Nat Biotech 2020, Mar 16.
A drug discovery platform to identify compounds that inhibit EGFR triple mutants. Nat Chem Bio2020, Feb 24.
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. Nat Comms 2020, Feb 5.
Autism-Misregulated eIF4G Microexons Control Synaptic Translation and Higher Order Cognitive Functions. Mol Cell 2020, Jan 29.
The entry of nanoparticles into solid tumours. Nat Mater 2020 Jan 13.
Driving Innovation in Medicine
Discoveries made in basic science are the foundation for all future progress in medicine. Emerging genomic and stem cell technologies hold the promise of personalized treatments that are tailored to patient’s unique genetic makeup and physiology. Through our collaborative approach, the Donnelly Centre is in a position to make breakthrough discoveries in biology and to lead the world in advancing personalized medicine.
Your gift to the Donnelly Centre allows researchers to explore new and innovative ideas that will transform our understanding of biology. It supports discovery that will unearth the cause of human disease, advance diagnosis and disease detection, create personalized therapies, and reverse injury through regenerative medicine.